Attenuation of experimental allergic encephalomyelitis in complement component 6-deficient rats is associated with reduced complement C9 deposition, P-selectin expression, and cellular infiltrate in spinal cords

Journal of Immunology

Volumn 168, Issue 9, 2002, Pages 4293-4300

  Tran, Giang T ^a   Hodgkinson, Suzanne J ^a   Carter, Nicole ^a   Killingsworth, Murray ^a   Spicer, S Timothy ^a   Hall, Bruce M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C9; COMPLEMENT MEMBRANE ATTACK COMPLEX; MYELIN BASIC PROTEIN; PADGEM PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BASOPHIL; CELL COUNT; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; LEUKOCYTE COUNT; MACROPHAGE ACTIVATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD; STRAIN DIFFERENCE; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 0036569324     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.9.4293     Document Type: Article

References (58)

1. Cellular events in the induction of experimental allergic encephalomyelitis
2. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination
3. The role of helper T cell subsets in autoimmune diseases
4. Cytokine-directed therapies in multiple sclerosis and experimental autoimmune encephalomyelitis
5. The role of complement in the pathogenesis of experimental allergic encephalomyelitis
6. The role of complement in disorders of the nervous system
7. Regulation of the complement membrane attack pathway
8. Expression of the adhesion molecules Mac-1 and L-selectin on neutrophils in acute pancreatitis is protease- and complement-dependent
9. The lectin pathway of the complement system
10. The lectin pathway of complement activation
11. Allergic encephalomyelitis: Effect of complement depletion with cobra venom
12. Prevention of experimental allergic encephalomyelitis with cobra venom factor
13. Experimental allergic encephalomyelitis in cobra venom factor-treated and C4-deficient guinea pigs
14. Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies
15. Complement depletion affects demyelination and inflammation in experimental allergic neuritis
16. Complement depletion suppresses Lewis rat experimental allergic neuritis
17. Attenuation of experimental autoimmune demyelination in complement-deficient mice
18. Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice
19. Role of the complement C3 protein in the control of the specific immune response
20. A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specific T cells
21. Complement defense mechanisms
22. The role of complement in autoimmunity
23. The demyelinating potential of Abs to myelin oligodendrocyte glycoprotein is related to their ability to fix complement
24. Soluble recombinant complement receptor I inhibits inflammation and demyelination in Ab-mediated demyelinating experimental allergic encephalomyelitis
25. Killing of rat glial cells by complement: Deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis
26. Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis
27. Hereditary C6 deficiency in a strain of PVG/c rats
28. The cellular basis of cardiac allograft rejection. VIII. Mechanisms underlying delayed allograft rejection in PVG C6-deficient rats
29. + rat strains
30. + T cell depletion prevents proteinuria in active Heymann nephritis
31. Immunohistochemical localisation of terminal complement component C9 in experimental allergic encephalomyelitis
32. Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)l cells that is augmented by IL-4
33. Induction of tolerance with nondepleting anti-CD4 monoclonal Abs is associated with down-regulation of TH2 cytokines
34. Mycophenolate mofetil treatment accelerates recovery from experimental allergic encephalomyelitis
35. Role of T cells in the mediation of Heymann nephritis. II. Identification of Th1 and cytotoxic cells in glomeruli
36. Magnetic resonance imaging and peripheral blood abnormalities in experimental allergic encephalomyelitis
37. Fluctuations of T- and B-cell subsets in basic protein-induced experimental allergic encephalomyelitis (EAE) in long-tailed macaques
38. Serial analysis of peripheral blood T-cell phenotypes and myelin basic protein reactivity in experimental allergic encephalomyelitis
39. Human immunoglobulin G and immunoglobulin G subclasses: Biochemical, genetic, and clinical aspects
40. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease
41. An unexpected version of horror autotoxicus: Anaphylactic shock to a self-peptide
42. The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells
43. Enhancement by the complement membrane attack complex of TNF-α-induced endothelial cell expression of E-selectin and ICAM-1
44. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells
45. The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity
46. Expression of Clq, a subcomponent of the rat complement system, is dramatically enhanced in brains of rats with either Boma disease or experimental allergic encephalomyelitis
47. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system
48. Complement expression in human brain: Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines
49. Complement regulatory protein expression by a human oligodendrocyte cell line: Cytokine regulation and comparison with astrocytes
50. Induction of C3 expression in astrocytes is regulated by cytokines and Newcastle disease virus
51. Expression of complement components of the alternative pathway by glioma cell lines
52. Expression of complement in the brain: Role in health and disease
53. Rapid induction of neutrophil-endothelial adhesion by endothelial complement fixation
54. Neutrophil adhesion inhibition prolongs survival of cardiac allografts with hyperacute rejection
55. Inhibition of neutrophil adhesion and the membrane attack complex of complement synergistically prolongs cardiac xenograft survival
56. The role of CD1 lb/CD18 mediated neutrophil adhesion in complement deficient xenograft recipients
57. Complement activation occurs on subendothelial extracellular matrix in vitro and is initiated by retraction or removal of overlying endothelial cells
58. Some misconceptions about understanding autoimmunity through experiments with knockouts